Skip to main content
Premium Trial:

Request an Annual Quote

Like Bert and Ernie

Creating a company goes a lot more smoothly when everyone involved already knows one another. Robert Langer and Terry McGuire have launched 13 companies over the last 15 years -- Langer supplies the science from his lab at MIT, and McGuire provides the venture capital. They are, according to the Wall Street Journal, a "model for other venture capitalists scrambling to commercialize new drug and medical-device research."

 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.